2022 FACTA Conference Brisbane
Keynote 1 – Prof Thomas Kraemer – New insights in postmortem toxicology
Keynote 3 – Prof Thomas Kraemer – Hair Analysis – Where are we standing
Keynote 5 – A_Prof Vicki Kotsirilos
Keynote 6 – Prof Olaf Drummer
Keynote 7 – Prof Thomas Kraemer – How to handle the big data problem in analytical forensic toxicology using machine learning
OP1 – Andrew Griffiths – The first ever reported death due to acetone ingestion. Or is it
OP2 – Vanessa Shaw – Panic at the disco_ drug use at NSW music festivals and the NSW drug surveillance strategy
OP3 – Eric Teoh – An interesting case study of a first coronial death involving both Flualprazolam and Etodesnitazene in South Australia
OP4 – Michelle Johnston – Katom Ingestion in a Coronial and Driver Case
OP5 – Michaela Kenneally – Overdose of Genvoya_ an antiretroviral treatment for HIV
OP12 – Rebekka Syrjanen – Acute intoxications involving novel benzodiazepines in the Australian EDNAV cohort 2020-2021
OP16 – Peter Stockham – Characteristics of gamma-hydroxybutyrate (GHB) intoxications in the emergency department
OP17 – Ben Hatfield_ Philip Tynan – Wastewater Drug Residue Testing in the Workplace during the COVID-19 pandemic
OP18 – Susan Britza – In vitro demonstration of herbal exacerbation of paracetamol-induced hepatotoxicity
OP20 – Tom Sheehan – The purity and dose of MDMA in powders, capsules and tablets from seizures in New Zealand 2020-2021
OP22 – Andrew Griffiths – Designer benzodiazepines in Queensland – an update on recent trends
OP23 – Richard Bade – Monitoring Novel Psychoactive Substances in 12 countries over the New Year period_ Case Studies over 2019-20 and 2020-21
OP24 – Daniel Pasin – HighResNPS_ an introduction and the current status of the crowd-sourced mass spectral database for new psychoactive substances
OP26 – Emma Partridge – Trends in benzodiazepine-type NPS in South Australian forensic toxicology casework
OP27 – Daniel Pasin – Evaluating HighResNPS as a tool for suspect screening of new psychoactive substances
OP32 – Madysen Elbourne- GC-MS profiling of equine urine for longitudinal assessments
OP33 – Kathy Tou – Complementary targeted_non-targeted LC-HRMS screening of biomarkers_ DIA or DDA
OP36 – Kerrilee Allan – Targeted LC_MS_MS for the identification and quantitation of 252 basic drugs and metabolites from whole blood
OP37 – Flair Bahadory – Development and validation of a fast and sensitive LC–MS-MS method for the screening of 111 compounds in forensic samples
OP38 – Bethany Keen – 3-O-Methyldopa as an indicator of dopaminergic manipulation in equine plasma